Riskpilot← Back to searchSign inGet full accessMeliora-Vision AB
ABActiveOrg 5590059522Valhallavägen 35Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20150 employees
Revenue 2024
SEK 0
EBITDA margin
—
+15% vs 2023
Equity ratio
76.1%
Financial strength
Net profit 2024
SEK -11K
+15% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -11K | +15% |
| Net profit | SEK -11K | +15% |
| Total assets | SEK 2,7M | +0% |
| Equity | SEK 2M | -1% |
| Employees | 0 | — |
Legal name
Meliora-Vision AB
Org number
5590059522
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
2 mars 2015
Share capital
SEK 60 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolagets verksamhet ska vara att driva utveckling av medicinsk teknisk utrustning.
Address
Valhallavägen 35
Email
thomas.larzon@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −30 | −15 | −16 | −13 | −11 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −30 | −15 | −16 | −13 | −11 |
| Net financials | — | — | — | — | — |
| Profit before tax | −30 | −15 | −16 | −13 | −11 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −30 | −15 | −16 | −13 | −11 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 488 | 2 693 | 2 676 | 2 665 | 2 653 |
| Equity | 2 075 | 2 059 | 2 043 | 2 030 | 2 019 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 414 | 634 | 632 | 635 | 634 |
| Total debt | 414 | 634 | 632 | 635 | 634 |
EBITDA margin
-1100000.0%
This company
15.8%
Market median
-6962125% vs market
20202024
Equity ratio
76.1%
This company
38.2%
Market median
+99% vs market
20202024
Return on equity
-0.5%
This company
18.4%
Market median
-103% vs market
20202024
Net profit margin
-1100000.0%
This company
8.1%
Market median
-13580347% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TL Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Meliora-Vision AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Lars Larzon | Chief Executive Officer | 0 companies |
| Karl Anders Henrik Nyman | Chairman | 0 companies |
| Cecilia Linnéa Elisabeth Almkvist | Board of Directors | 0 companies |
| Ulf Lennart Öster | Board of Directors | 0 companies |
| Daniel Lennart Karlsson | Board of Directors | 0 companies |